Advertisement
Canada markets close in 1 hour 40 minutes
  • S&P/TSX

    22,040.14
    +168.18 (+0.77%)
     
  • S&P 500

    5,074.38
    +63.78 (+1.27%)
     
  • DOW

    38,516.89
    +276.91 (+0.72%)
     
  • CAD/USD

    0.7322
    +0.0021 (+0.28%)
     
  • CRUDE OIL

    83.37
    +1.47 (+1.79%)
     
  • Bitcoin CAD

    91,330.78
    +314.29 (+0.35%)
     
  • CMC Crypto 200

    1,437.16
    +22.40 (+1.58%)
     
  • GOLD FUTURES

    2,342.40
    -4.00 (-0.17%)
     
  • RUSSELL 2000

    2,008.68
    +41.20 (+2.09%)
     
  • 10-Yr Bond

    4.5880
    -0.0350 (-0.76%)
     
  • NASDAQ

    15,717.14
    +265.83 (+1.72%)
     
  • VOLATILITY

    15.92
    -1.02 (-6.02%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     

Why Oscar Health Stock Tumbled by 22% on Tuesday

Why Oscar Health Stock Tumbled by 22% on Tuesday

One of the sicker stocks on the market Tuesday was next-generation health insurance provider Oscar Health (NYSE: OSCR). The company's share price fell by almost 22% following the publication of a downbeat analyst note from an influential investment bank. Goldman Sachs analyst Nathan Rich launched coverage of the U.S. managed care healthcare segment. The analyst is initiating his coverage of Oscar Health by tagging it with a sell recommendation, at a price target of $6.50 per share -- a queasy 38% below Monday's close.